Literature DB >> 1682659

Mefloquine for multidrug-resistant malaria.

C Luxemburger, F Nosten, F ter Kuiile, L Frejacques, T Chongsuphajaisiddhi, N J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1682659     DOI： 10.1016/0140-6736(91)92131-k

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Antimalarial pharmacokinetics and treatment regimens.

Authors:  N J White
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

2.  New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.

Authors:  S Krudsood; S Looareesuwan; N Tangpukdee; P Wilairatana; W Phumratanaprapin; W Leowattana; K Chalermrut; S Ramanathan; V Navaratnam; P Olliaro; M Vaillant; J R Kiechel; W R J Taylor
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

3.  Mefloquine.

Authors:  N J White
Journal:  BMJ       Date:  1994-01-29

Review 4.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 5.  New antimalarials. A risk-benefit analysis.

Authors:  F Nosten; R N Price
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 6.  Adverse effects of antimalarials. An update.

Authors:  G A Luzzi; T E Peto
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

Review 7.  Antimalarial drug toxicity: a review.

Authors:  W Robert J Taylor; Nicholas J White
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  CNS adverse events associated with antimalarial agents. Fact or fiction?

Authors:  P A Phillips-Howard; F O ter Kuile
Journal:  Drug Saf       Date:  1995-06       Impact factor: 5.606

Review 9.  Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.

Authors:  Kate McKeage; Lesley Scott
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.

Authors:  Sue J Lee; Feiko O Ter Kuile; Ric N Price; Christine Luxemburger; François Nosten
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.